Literature DB >> 33777646

New Developments in Cholinergic Imaging in Alzheimer and Lewy Body Disorders.

Chesney E Craig1, Nicola J Ray1, Martijn L T M Müller2,3, Nicolaas I Bohnen2,3,2,4.   

Abstract

PURPOSE OF REVIEW: This paper aims to review novel trends in cholinergic neuroimaging in Alzheimer and Lewy body parkinsonian disorders. RECENT
FINDINGS: The spectrum of cholinergic imaging is expanding with the availability of spatially more precise radioligands that allow assessment of previously less recognized subcortical and cortical structures with more dense cholinergic innervation. In addition, advances in MRI techniques now allow quantitative structural or functional assessment of both the cholinergic forebrain and the pedunculopontine nucleus, which may serve as non-invasive prognostic predictors. Multimodal imaging approaches, such as PET-MRI or multiligand PET offer new insights into the dynamic and interactive roles of the cholinergic system at both local and larger-scale neural network levels.
SUMMARY: Our understanding of the heterogeneous roles of the cholinergic system in age-related diseases is evolving. Multimodal imaging approaches that provide complimentary views of the cholinergic system will be necessary to shed light on the impact of cholinergic degeneration on regional and large-scale neural networks that underpin clinical symptom manifestation in neurodegeneration.

Entities:  

Keywords:  Alzheimer’s disease; Lewy body dementias & Parkinson’s disease; cholinergic; imaging

Year:  2020        PMID: 33777646      PMCID: PMC7992054          DOI: 10.1007/s40473-020-00221-6

Source DB:  PubMed          Journal:  Curr Behav Neurosci Rep


  59 in total

Review 1.  Brain imaging in patients with freezing of gait.

Authors:  Anna L Bartels; Klaus L Leenders
Journal:  Mov Disord       Date:  2008       Impact factor: 10.338

2.  Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease.

Authors:  Matthew J Barrett; Scott A Sperling; Jamie C Blair; Cody S Freeman; Joseph L Flanigan; Mark E Smolkin; Carol A Manning; T Jason Druzgal
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-06-07       Impact factor: 10.154

3.  Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6).

Authors:  M M Mesulam; E J Mufson; B H Wainer; A I Levey
Journal:  Neuroscience       Date:  1983-12       Impact factor: 3.590

4.  Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey.

Authors:  M M Mesulam; E J Mufson; A I Levey; B H Wainer
Journal:  J Comp Neurol       Date:  1983-02-20       Impact factor: 3.215

5.  Brain cholinergic alterations in idiopathic REM sleep behaviour disorder: a PET imaging study with 18F-FEOBV.

Authors:  Marc-Andre Bedard; Meghmik Aghourian; Camille Legault-Denis; Ronald B Postuma; Jean-Paul Soucy; Jean-François Gagnon; Amélie Pelletier; Jacques Montplaisir
Journal:  Sleep Med       Date:  2019-01-06       Impact factor: 3.492

6.  Gait speed in Parkinson disease correlates with cholinergic degeneration.

Authors:  Nicolaas I Bohnen; Kirk A Frey; Stephanie Studenski; Vikas Kotagal; Robert A Koeppe; Peter J H Scott; Roger L Albin; Martijn L T M Müller
Journal:  Neurology       Date:  2013-09-27       Impact factor: 9.910

Review 7.  The fate of the brain cholinergic neurons in neurodegenerative diseases.

Authors:  Giancarlo Pepeu; Maria Grazia Giovannini
Journal:  Brain Res       Date:  2017-06-23       Impact factor: 3.252

8.  History of falls in Parkinson disease is associated with reduced cholinergic activity.

Authors:  N I Bohnen; M L T M Müller; R A Koeppe; S A Studenski; M A Kilbourn; K A Frey; R L Albin
Journal:  Neurology       Date:  2009-11-17       Impact factor: 9.910

Review 9.  Can neuroimaging predict dementia in Parkinson's disease?

Authors:  Juliette H Lanskey; Peter McColgan; Anette E Schrag; Julio Acosta-Cabronero; Geraint Rees; Huw R Morris; Rimona S Weil
Journal:  Brain       Date:  2018-09-01       Impact factor: 13.501

10.  Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBV.

Authors:  Siamak Nejad-Davarani; Robert A Koeppe; Roger L Albin; Kirk A Frey; Martijn L T M Müller; Nicolaas I Bohnen
Journal:  Mol Psychiatry       Date:  2018-08-06       Impact factor: 15.992

View more
  1 in total

1.  Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.

Authors:  Julia Schumacher; Nicola J Ray; Calum A Hamilton; Paul C Donaghy; Michael Firbank; Gemma Roberts; Louise Allan; Rory Durcan; Nicola Barnett; John T O'Brien; John-Paul Taylor; Alan J Thomas
Journal:  Brain       Date:  2022-06-03       Impact factor: 15.255

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.